Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

IRFI-117, an adenosine A1 antagonist for oral or i.v. dosing

May 21, 1998

NO-NSAIDs retain antiinflammatory/analgesic potency, with fewer GI side effects

May 20, 1998

DEHOP phase II data discussed at Digestive Disease Week

May 20, 1998

S-Nitrosocaptopril combines NO-donor and ACE-inhibitor effects in a single molecule

May 20, 1998

Profile of eplerenone, a novel aldosterone antagonist from Searle

May 20, 1998

DISC HSV reported to be safe and immunogenic in phase I trials

May 20, 1998

Helicase-primase, an enzyme target for the design of new antiviral agents

May 19, 1998

IRL-3630: a bifunctional ET antagonist for respiratory ailments

May 12, 1998

Comparative studies of L-0066 in animal models of allergic bronchial inflammation

May 11, 1998

Levalbuterol shows improved therapeutic ratio over racemic albuterol

May 8, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...